ONS Guidelines Article
Supplementary Material for ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity
- Guideline panel conflict of interest disclosures
- PICO questions
- Evidence-to-Decision Frameworks
- EGFR inhibitor rash prevention—oral antibiotics (doxycycline, tetracycline, minocycline) and usual care vs. usual care
- EGFR inhibitor rash treatment—topical corticosteroids with oral antibiotics and usual care vs. usual care
- Hand-foot skin reaction prevention—topical urea and topical corticosteroids vs. usual care
- Hand-foot syndrome prevention—oral pyridoxine (vitamin B6) vs. no oral pyridoxine (vitamin B6)
- Hand-foot syndrome prevention—cooling procedures vs. no cooling procedures
- Chemotherapy-induced alopecia prevention—scalp cooling vs. no scalp cooling
- Chemotherapy-induced alopecia prevention—minoxidil vs. usual care